Concepedia

Matthew A. Schiffler

MA

Statistics

Publications

10

Citations

335

H-Index

10

Active since

2010

Affiliations

Eli Lilly (United States)(Current)

Harvard University

Matthew A. Schiffler is an author at Eli Lilly (United States) specializing in pharmacology, enzyme inhibition, and medicinal chemistry.

ORCID

Publications per year

2010–2018

10

Publications

10

Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic Aneurysm

Prabhakar K. Jadhav, Matthew A. Schiffler, Kostas Gavardinas et al. · ACS Medicinal Chemistry Letters · 2014 · 67 citations · Full text

, , +13

Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors

Matthew A. Schiffler, Stephen Antonysamy, Shobha Bhattachar et al. · Journal of Medicinal Chemistry · 2015 · 54 citations · Full text

, , +16

An Enantioselective Total Synthesis of (+)‐Peloruside A

Meredeth A. McGowan, Christian P. Stevenson, Matthew A. Schiffler et al. · Angewandte Chemie International Edition · 2010 · 51 citations

, , +6

Discovery and characterization of [(cyclopentyl)ethyl]benzoic acid inhibitors of microsomal prostaglandin E synthase-1

Katherine M. Partridge, Stephen Antonysamy, Shobha Bhattachar et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 27 citations · Full text

, , +6

Characterization of 3,3-dimethyl substituted N-aryl piperidines as potent microsomal prostaglandin E synthase-1 inhibitors

Steven L. Kuklish, Stephen Antonysamy, Shobha Bhattachar et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 26 citations · Full text

, , +11

1–5 of 10